NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/09/2024
Back to search
Official data from USPTO
GMPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
07/09/2024
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
02/18/2022
Registration date
07/09/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/09/2024
Last transaction
07/09/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
03
Owner location
Seocho-gu, Seoul, KR
Examiner
NUNLEY, CHRISTOPHER MICHAEL
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording of "GMPHARM", where each "M" is in a turquoise color and is shaped like two arrow heads arranged next to each other, and where "G" and "PHAR" are in a gray color.
Holders and representatives
Holders
GMPHARM
Representatives
Jun S. Ha LOZA & LOZA, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Magnesium-based nutritional supplements; vitamin dietary supplement; vitamin and mineral supplements; vitamins; vitamin A; B vitamins; Vitamin C; Vitamin D; dietary supplement; Health supplements, namely, dietary supplements; Nutritional supplements containing zinc as the main ingredient; nutritional supplements; Multivitamin; Nutritional supplements containing iron as the main ingredient; Calcium-based nutritional supplements
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/25/2024
PUBO
PUBLISHED FOR OPPOSITION
04/23/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/04/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/04/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/11/2023
GNFR
FINAL REFUSAL E-MAILED
12/11/2023
CNFR
FINAL REFUSAL WRITTEN
12/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/01/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/01/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/09/2022
GNRT
NON-FINAL ACTION E-MAILED
12/09/2022
CNRT
NON-FINAL ACTION WRITTEN
12/09/2022
DOCK
ASSIGNED TO EXAMINER
12/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/23/2022
NWAP
NEW APPLICATION ENTERED
02/22/2022
Continuous trademark protection
Get notified about every new filing that threatens GMPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.